Onyx ONE Clear Atrial Fibrillation (AF) Subanalysis - TCT Connect 2020
Onyx ONE Clear Complex PCI Subanalysis - TCT Connect 2020
Onyx ONE: aspirin vs. P2Y12 after 1-month dual antiplatelet therapy for high bleeding risk patients
Onyx ONE Acute Coronary Syndromes (ACS) Subanalysis - TCT Connect 2020
Evidence counts: Latest data from Onyx One-month DAPT program & Renal Denervation – GulfPCR-GIM 2020
Drugs and devices synergy: optimal DAPT & switching strategies - Round Table Webinar
One-Month DAPT
One month DAPT is the new standard of care for stable patients?_Baber_Coronary On Demand
Shouvik Haldar, HRS 2019 - Atrial Fibrillation and the CASA-AF study
Recent Update on DAPT Strategy for PCI Patients, Prof. Lee, Won Jae
TCT2020 summary and overview of day 1 #TCTConnect
MASTER DAPT clinical trial review
XIENCE 90/28: Assessment of 3-month and 1-month DAPT in HBR patients - TCT Connect 2020
TCT Connect 2020: The TARGET FFR Trial — Dr Damien Collison
Patients with Resistant Hypertension in the Global SYMPLICITY Registry - TCT Connect 2020
TCT-Connect-2020-IREMMI-Trial-Rodrigo-Estévez-Loureiro
MASTER DAPT trial: dual antiplatelet therapy after coronary stenting - AICT-AsiaPCR 2021
First-in-Human Experience with a Novel Temporary Pacing Lead
Day 2 Highlights | TCT 2020
Day 1 Highlights | TCT 2020
